FMED vs. XOVR ETF Comparison
Comparison of Fidelity Disruptive Medicine ETF (FMED) to ERShares Private-Public Crossover ETF (XOVR)
FMED
Fidelity Disruptive Medicine ETF
FMED Description
The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$26.38
Average Daily Volume
5,352
10
XOVR
ERShares Private-Public Crossover ETF
XOVR Description
Grade (RS Rating)
Last Trade
$15.67
Average Daily Volume
10,812
30
Performance
| Period | FMED | XOVR |
|---|---|---|
| 30 Days | 4.17% | 1.95% |
| 60 Days | 7.76% | 3.70% |
| 90 Days | 12.58% | -0.20% |
| 12 Months | 14.35% | 30.90% |
FMED Underweight 28 Positions Relative to XOVR
| Symbol | Grade | Weight | |
|---|---|---|---|
| META | B | -6.0% | |
| NVDA | D | -5.59% | |
| GOOGL | D | -5.37% | |
| ORCL | B | -4.77% | |
| CRM | D | -4.45% | |
| DASH | C | -4.03% | |
| SPOT | C | -3.88% | |
| RMD | B | -3.78% | |
| ANET | C | -3.59% | |
| CPRT | F | -3.42% | |
| MPWR | C | -3.25% | |
| CPAY | C | -3.17% | |
| MDB | D | -3.17% | |
| APP | B | -3.15% | |
| ABNB | D | -3.05% | |
| SNPS | D | -3.04% | |
| UTHR | C | -2.96% | |
| DDOG | D | -2.9% | |
| PCTY | D | -2.69% | |
| ULTA | D | -2.61% | |
| TOST | C | -2.56% | |
| DBX | D | -2.5% | |
| DKNG | D | -2.47% | |
| PSTG | D | -2.16% | |
| APPF | D | -2.15% | |
| MEDP | D | -2.13% | |
| CFLT | F | -1.86% | |
| SMCI | F | -1.71% |
FMED: Top Represented Industries & Keywords
XOVR: Top Represented Industries & Keywords
Compare ETFs
